GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solara Active Pharma Sciences Ltd (BOM:541540) » Definitions » Market Cap

Solara Active Pharma Sciences (BOM:541540) Market Cap : ₹16,787 Mil (As of Jun. 09, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Solara Active Pharma Sciences Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Solara Active Pharma Sciences's share price for the quarter that ended in Mar. 2024 was ₹343.265. Solara Active Pharma Sciences's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 39 Mil. Therefore, Solara Active Pharma Sciences's market cap for the quarter that ended in Mar. 2024 was ₹13,407 Mil.

Solara Active Pharma Sciences's quarterly market cap increased from Sep. 2023 (₹12,858 Mil) to Dec. 2023 (₹12,996 Mil) and increased from Dec. 2023 (₹12,996 Mil) to Mar. 2024 (₹13,407 Mil).

Solara Active Pharma Sciences's annual market cap declined from Mar. 2022 (₹23,943 Mil) to Mar. 2023 (₹11,821 Mil) but then increased from Mar. 2023 (₹11,821 Mil) to Mar. 2024 (₹13,407 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Solara Active Pharma Sciences's Enterprise Value for Today is ₹26,743 Mil.


Solara Active Pharma Sciences Market Cap Historical Data

The historical data trend for Solara Active Pharma Sciences's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solara Active Pharma Sciences Market Cap Chart

Solara Active Pharma Sciences Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial 11,900.89 50,095.21 23,942.89 11,821.17 13,406.80

Solara Active Pharma Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,821.17 13,741.55 12,857.86 12,996.43 13,406.80

Competitive Comparison of Solara Active Pharma Sciences's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Solara Active Pharma Sciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solara Active Pharma Sciences's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Solara Active Pharma Sciences's Market Cap distribution charts can be found below:

* The bar in red indicates where Solara Active Pharma Sciences's Market Cap falls into.



Solara Active Pharma Sciences Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Solara Active Pharma Sciences's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=₹343.265*39.0567
=₹13,407

Solara Active Pharma Sciences's Market Cap for the quarter that ended in Mar. 2024 is calculated as

Market Cap (Q: Mar. 2024 )=Share Price (Q: Mar. 2024 )*Shares Outstanding (EOP) (Q: Mar. 2024 )
=₹343.265*39.0567
=₹13,407

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Solara Active Pharma Sciences  (BOM:541540) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Solara Active Pharma Sciences Market Cap Related Terms

Thank you for viewing the detailed overview of Solara Active Pharma Sciences's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Solara Active Pharma Sciences (BOM:541540) Business Description

Traded in Other Exchanges
Address
27. Vandaloor Kelambakkam Road, 2nd Floor. Admin Block, Melakottaiyur (Post), Keelakottaiyur Village, Chennai, TN, IND, 600 127
Solara Active Pharma Sciences Ltd is engaged in Active Pharmaceutical Ingredients manufacturer (API) in India. It manufactures and develops APIs and offers services, including CRAMS and contract manufacturing for APIs. The company offers products and services, such as Anaesthetic, Analgesics, Antiviral, Retinod, Anti-emetic, Antimalarial, Diuretic, Muscle relaxant, Antiallergics, Antihypertensive, Calcimimetic agent, Anti-seizure, Antigout, Cardiovascular, Anti-infective, Cough suppressant and others. It also offers contract services including contract development and manufacturing, analytical services. The group has a business presence in the Asia Pacific, Europe, North America, South America, and other places, of which the majority of income is generated from the Asia Pacific countries.

Solara Active Pharma Sciences (BOM:541540) Headlines

No Headlines